Existing cancer drug lenalidomide could restore aging immune system

UCSF “fountain of youth” pill could restore aging immune system

The cancer drug lenalidomide, a a derivative of thalidomide introduced in 2004, is marketed as Revlimid by Celgene.

Lenalidomide has been used to successfully treat both inflammatory disorders and cancers in the past 10 years.

However, as with any scientific research, one should not interpret the result as ready remedy.